VHL vitasora health limited

Cadence1,I have already posted the data on this and the link a...

  1. 5,038 Posts.
    lightbulb Created with Sketch. 454
    Cadence1,

    I have already posted the data on this and the link a couple of weeks ago.

    In Summary

    The license applies specifically to the United States and Canada and to Transgene’s TG4010 expressing MUC1 and IL2, and TG4001 expressing HPV antigens and IL2.

    VHL - would get up to $9M for TG4010 and up to $3M for TG4001 (I see from another document they got at least $2.5M for TG4001)

    In addition Virax will receive a royalty on net sales of the licensed products in North America.

    So only North America sales royalty for TG4010 and this MUC1 and IL2 must apply to.

    http://bioresearchcentral.pharmaloco.com/news_detail/Virax+Grants+Transgene+Co-X-Gene+Technology+License+for+Two+/17905/index.html

    LOTM
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $46.40M
Open High Low Value Volume
2.8¢ 2.8¢ 2.7¢ $2.318K 83.08K

Buyers (Bids)

No. Vol. Price($)
2 504704 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 2243930 1
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.